Expression Landscape of Cancer-Foxp3 and its Prognostic Value in Pancreatic Adenocarcinoma

34 Pages Posted: 14 Feb 2024

See all articles by Ruining Gong

Ruining Gong

Qingdao University

Jia Wang

Qingdao University

Yihai Xing

Qingdao University

Jigang Wang

Qingdao University - Affiliated Hospital

Xianghan Chen

Qingdao University

Ke Lei

Qingdao University

Qian Yu

Qingdao University

Chenyang Zhao

Qingdao University

Sainan Li

Chinese Academy of Sciences (CAS)

Yuxing Zhang

Qingdao University

Hongxia Wang

Shanghai Jiao Tong University (SJTU) - Department of Oncology

He Ren

Qingdao University

Abstract

FOXP3, a key identifier of Treg, has also been identified in tumor cells, which is referred to as cancer-FOXP3 (c-FOXP3). Human c-FOXP3 undergoes multiple alternative splicing events, generating several isoforms, like c-FOXP3FL and c-FOXP3Δ3. Previous research on c-FOXP3 often ignore its cellular source (immune or tumor cells) and isoform expression patterns, which may obscure our understanding of its clinical significance. Our immunohistochemistry investigations which conducted across 18 tumors using validated c-FOXP3 antibodies revealed distinct expression landscapes for c-FOXP3 and its variants, with the majority of tumors exhibited a predominantly expression of c-FOXP3Δ3. In pancreatic adenocarcinoma (PAAD), we further discovered a potential link between nuclear c-FOXP3Δ3 in tumor cells and poor prognosis. Overexpression of c-FOXP3Δ3 in tumor cells was associated with metastasis. This work elucidates the expression pattern of c-FOXP3 in pan-cancer and indicates its potential as a prognostic biomarker in clinical settings, offering new perspectives for its clinical application

Note:
Funding declaration: This work was supported by National Science Foundation of China (No. 82125026; 82330081), the Taishan Scholars Program of Shandong Province (No. Ts20190987) and the Major State Basic Research Development Program of Natural Science Foundation of Shandong Province (No. ZR2020ZD11) to H. Ren. The National Science Foundation of China (No. 82303933) to Q. Yu. Natural Science Foundation of Shandong (No. ZR2023QH122) to J. Wang, and Shandong Province Postdoctoral Innovation Talent Program (No.SDBX2022022) to Y. Zhang.

Conflict of Interests: The authors declared no conflict of interest.

Ethical Approval: The usage of these specimens was approved by the Ethics Committee of the Affiliated Hospital of Qingdao University (Permission No. QYFYWZLL28015).

Keywords: cancer-FOXP3, splice variants, antibodies, pan-cancer, prognosis

Suggested Citation

Gong, Ruining and Wang, Jia and Xing, Yihai and Wang, Jigang and Chen, Xianghan and Lei, Ke and Yu, Qian and Zhao, Chenyang and Li, Sainan and Zhang, Yuxing and Wang, Hongxia and Ren, He, Expression Landscape of Cancer-Foxp3 and its Prognostic Value in Pancreatic Adenocarcinoma. Available at SSRN: https://ssrn.com/abstract=4720635 or http://dx.doi.org/10.2139/ssrn.4720635

Ruining Gong

Qingdao University ( email )

Jia Wang

Qingdao University ( email )

Yihai Xing

Qingdao University ( email )

Jigang Wang

Qingdao University - Affiliated Hospital ( email )

China

Xianghan Chen

Qingdao University ( email )

Ke Lei

Qingdao University ( email )

Qian Yu

Qingdao University ( email )

Chenyang Zhao

Qingdao University ( email )

Sainan Li

Chinese Academy of Sciences (CAS) ( email )

Yuxing Zhang

Qingdao University ( email )

Hongxia Wang

Shanghai Jiao Tong University (SJTU) - Department of Oncology ( email )

Shanghai
China

He Ren (Contact Author)

Qingdao University ( email )

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
26
Abstract Views
167
PlumX Metrics